Yubo International Biotech Limited

YBGJ · OTC
Analyze with AI
12/31/2024
12/31/2022
12/31/2021
12/31/2020
Operating Activities
Net Income-$1,775-$1,205-$1,542-$712
Dep. & Amort.$183$28$21$13
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$249$1,246$492$800
Other Non-Cash$5$0$8$0
Operating Cash Flow-$1,338$68-$1,021$101
Investing Activities
PP&E Inv.$0-$40-$565-$97
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$118$0$0$0
Investing Cash Flow$118-$40-$565-$97
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$750
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$1,407$0$127$635
Financing Cash Flow$1,407$0$127$1,385
Forex Effect-$187-$38$103-$7
Net Chg. in Cash$1-$9-$1,355$1,381
Supplemental Information
Beg. Cash$6$28$1,383$1
End Cash$7$18$28$1,383
Free Cash Flow-$1,338$28-$1,586$4
Yubo International Biotech Limited (YBGJ) Financial Statements & Key Stats | AlphaPilot